Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
The effect of metformin on aminotransferase levels, metabolic parameters and body mass index in nonalcoholic fatty liver disease patients: a metaanalysis
While short-term use may improve insulin sensitivity, chronic exposure can worsen metabolic conditionsespecially in those already struggling with blood sugar control
Upstream regulatory mechanisms of necroptosis in DKD involve distinct epigenetic, transcriptional, and microenvironmental factors
Semaglutide has been shown to reduce -amyloid deposition, improved spatial memory, and enhanced cerebral glucose metabolism (Zhang et al., 2024)